Profile data is unavailable for this security.
About the company
Malin Corporation PLC is focused on investing in life sciences companies. The Company’s assets give investors access to life sciences businesses with exposure across diverse modalities, therapeutic areas and geographies. Its business includes Poseida, Viamet, Xenex, WaveBreak, KNOW Bio, and Artizan. Poseida is a clinical-stage biopharmaceutical company building a pipeline of Chimeric antigen receptor T cell (CAR-T) product candidates. Xenex is a commercial-stage medical device company focused on reducing healthcare-associated infections with its non-mercury, full-spectrum disinfection LightStrike Germ-Zapping robots. KNOW Bio is a life science company engaged in the fields of nitric oxide and precision light therapy. WaveBreak Therapeutics company focuses on the development of medicines for the treatment of protein-misfolding diseases including Alzheimer's and Parkinson's. Artizan is a biotechnology company.
- Revenue in EUR (TTM)0.00
- Net income in EUR0.00
- Incorporated2014
- Employees2.00
- LocationMalin Corporation PLCThe Lennox Building50 Richmond Street SouthDUBLIN D02 FK02IrelandIRL
- Phone+353 19015700
- Fax+353 19015701
- Websitehttps://malinplc.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZIM Laboratories Ltd | 35.16m | 649.73k | 32.30m | 577.00 | 49.43 | -- | 12.79 | 0.9187 | 1.44 | 1.44 | 78.03 | -- | -- | -- | -- | 6,548,695.00 | -- | 4.08 | -- | 6.64 | 55.93 | 48.54 | 1.85 | 4.24 | -- | 1.35 | -- | 0.00 | 3.16 | 6.42 | -29.46 | 29.84 | 17.10 | -- |
| Marinomed Biotech AG | 9.46m | 16.14m | 32.75m | 42.00 | 1.77 | -- | 2.00 | 3.46 | 10.07 | 10.07 | 5.32 | -3.06 | 0.9978 | -- | 5.11 | 225,266.40 | 170.19 | -42.38 | -- | -63.46 | 65.35 | 11.22 | 170.57 | -90.11 | -- | 28.72 | 2.03 | -- | -48.31 | -5.03 | -126.89 | -- | -- | -- |
| Labiana Health SA | 70.37m | 904.36k | 32.93m | 394.00 | 36.45 | 6.98 | 6.96 | 0.468 | 0.1251 | 0.1251 | 10.21 | 0.653 | 1.34 | 2.33 | 6.06 | 190,702.30 | 1.62 | -4.65 | 2.69 | -8.04 | 61.09 | 59.85 | 1.21 | -4.85 | 0.8573 | 1.23 | 0.6842 | -- | 13.33 | 6.49 | 105.73 | -17.33 | -11.04 | -- |
| Malin Corporation plc | 0.00 | 0.00 | 33.31m | 2.00 | -- | 0.7561 | 333.11 | -- | 0.00 | 0.00 | 0.00 | 10.18 | 0.00 | -- | -- | 0.00 | 0.00 | 8.14 | 0.00 | 8.56 | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 | -- | -- | -- | -- | -- | -- |
| Rockwell Medical Inc | 63.68m | -4.61m | 33.53m | 244.00 | -- | 1.08 | -- | 0.5266 | -0.1583 | -0.1583 | 2.20 | 0.9395 | 1.32 | 12.92 | 8.78 | 309,741.80 | -9.63 | -32.92 | -12.15 | -46.61 | 15.81 | 8.00 | -7.30 | -23.86 | 3.50 | -6.13 | 0.2141 | -- | 21.38 | 10.61 | 94.31 | -- | 11.47 | -- |
| Decibel Cannabis Company Inc | 67.63m | 7.62m | 33.92m | -- | 3.60 | 0.8619 | 2.83 | 0.5015 | 0.0264 | 0.025 | 0.198 | 0.1102 | 0.795 | 2.15 | 6.51 | -- | 8.96 | -0.0401 | 13.94 | -0.0595 | 21.98 | 20.03 | 11.27 | -0.0688 | 0.6086 | -5.57 | 0.4186 | -- | -12.89 | 71.51 | 810.61 | -- | -4.74 | -- |
| Kohjin Bio Co Ltd | 28.00m | 2.65m | 34.07m | 167.00 | 12.87 | 1.04 | 8.05 | 1.22 | 93.88 | 93.88 | 992.83 | 1,157.47 | 0.5768 | 3.51 | 4.58 | 30,386,960.00 | 5.45 | -- | 7.67 | -- | 43.01 | -- | 9.46 | -- | 1.49 | -- | 0.2443 | -- | 9.14 | -- | 106.44 | -- | -- | -- |
| Eastwood Bio-Medical Canada Inc | 367.87k | -254.81k | 34.10m | -- | -- | -- | -- | 92.69 | -0.006 | -0.006 | 0.0086 | -0.0225 | 2.17 | -- | 26.00 | -- | -150.26 | -71.29 | -- | -- | 63.91 | 56.40 | -69.27 | -57.09 | -- | -31.24 | -- | -- | -19.11 | -11.50 | 16.60 | -- | -- | -- |
| Hin Sang Group (Interntnl) Hldng Co Ltd | 10.30m | -4.32m | 34.13m | 185.00 | -- | 2.23 | -- | 3.31 | -0.0367 | -0.0367 | 0.0875 | 0.1299 | 0.1679 | 2.42 | 12.62 | 459,278.80 | -7.03 | -5.77 | -13.64 | -8.41 | 67.28 | 58.19 | -41.89 | -36.55 | 0.0735 | -0.3333 | 0.7032 | -- | -0.7882 | -12.21 | -34.48 | -- | -50.36 | -- |
| NicOx SA | 3.32m | -27.06m | 34.23m | 11.00 | -- | -- | -- | 10.32 | -0.3657 | -0.3657 | 0.045 | -0.0659 | 0.1034 | -- | 1.63 | 663,166.00 | -84.36 | -28.03 | -91.95 | -30.66 | -- | -- | -816.13 | -338.04 | -- | -56.80 | 1.48 | -- | 13.85 | 2.77 | -7.22 | -- | -- | -- |
| Rhone Ma Holdings Bhd | 45.70m | 2.92m | 34.34m | 205.00 | 15.81 | 0.8921 | 8.96 | 0.7516 | 0.0449 | 0.0449 | 0.7037 | 0.7959 | 0.8988 | 2.29 | 5.19 | -- | 5.87 | 6.05 | 7.20 | 7.35 | 30.65 | 27.97 | 6.53 | 6.64 | 2.05 | 17.24 | 0.1002 | 36.65 | 4.17 | 12.17 | 1.87 | 7.34 | -37.84 | 20.11 |
| Holder | Shares | % Held |
|---|---|---|
| Pentwater Capital Management LPas of 04 Apr 2025 | 1.10m | 25.40% |
| National Treasury Management Agency (Invt Mgmt)as of 04 Apr 2025 | 405.24k | 9.37% |
